Product Code: ETC7270075 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Gambia Pneumococcal Vaccine Market Overview |
3.1 Gambia Country Macro Economic Indicators |
3.2 Gambia Pneumococcal Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Gambia Pneumococcal Vaccine Market - Industry Life Cycle |
3.4 Gambia Pneumococcal Vaccine Market - Porter's Five Forces |
3.5 Gambia Pneumococcal Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Gambia Pneumococcal Vaccine Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Gambia Pneumococcal Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Gambia Pneumococcal Vaccine Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.9 Gambia Pneumococcal Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Gambia Pneumococcal Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in preventing pneumococcal diseases. |
4.2.2 Government initiatives to improve healthcare infrastructure and increase vaccination coverage. |
4.2.3 Growing investments in research and development for advanced pneumococcal vaccines. |
4.3 Market Restraints |
4.3.1 High cost associated with pneumococcal vaccines may limit accessibility, especially for low-income populations. |
4.3.2 Lack of healthcare professionals and infrastructure in remote areas may hinder the distribution and administration of vaccines. |
5 Gambia Pneumococcal Vaccine Market Trends |
6 Gambia Pneumococcal Vaccine Market, By Types |
6.1 Gambia Pneumococcal Vaccine Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Gambia Pneumococcal Vaccine Market Revenues & Volume, By Vaccine Type, 2021- 2031F |
6.1.3 Gambia Pneumococcal Vaccine Market Revenues & Volume, By Pneumococcal Conjugate Vaccine, 2021- 2031F |
6.1.4 Gambia Pneumococcal Vaccine Market Revenues & Volume, By Pneumococcal Polysaccharide Vaccine, 2021- 2031F |
6.2 Gambia Pneumococcal Vaccine Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Gambia Pneumococcal Vaccine Market Revenues & Volume, By Prevnar 13, 2021- 2031F |
6.2.3 Gambia Pneumococcal Vaccine Market Revenues & Volume, By Synflorix, 2021- 2031F |
6.2.4 Gambia Pneumococcal Vaccine Market Revenues & Volume, By Pneumovax 23, 2021- 2031F |
6.2.5 Gambia Pneumococcal Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Gambia Pneumococcal Vaccine Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Gambia Pneumococcal Vaccine Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.3.3 Gambia Pneumococcal Vaccine Market Revenues & Volume, By Intramuscular, 2021- 2031F |
6.3.4 Gambia Pneumococcal Vaccine Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4 Gambia Pneumococcal Vaccine Market, By End Users |
6.4.1 Overview and Analysis |
6.4.2 Gambia Pneumococcal Vaccine Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Gambia Pneumococcal Vaccine Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Gambia Pneumococcal Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Gambia Pneumococcal Vaccine Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Gambia Pneumococcal Vaccine Market Revenues & Volume, By Distribution Partner Companies, 2021- 2031F |
6.5.3 Gambia Pneumococcal Vaccine Market Revenues & Volume, By Non-governmental Organizations (NGO), 2021- 2031F |
6.5.4 Gambia Pneumococcal Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
7 Gambia Pneumococcal Vaccine Market Import-Export Trade Statistics |
7.1 Gambia Pneumococcal Vaccine Market Export to Major Countries |
7.2 Gambia Pneumococcal Vaccine Market Imports from Major Countries |
8 Gambia Pneumococcal Vaccine Market Key Performance Indicators |
8.1 Rate of vaccination coverage among target population groups. |
8.2 Number of government-funded vaccination programs implemented. |
8.3 Research and development investment in new vaccine technologies. |
8.4 Adherence to vaccination schedules among the population. |
8.5 Number of reported cases of pneumococcal diseases post-vaccination. |
9 Gambia Pneumococcal Vaccine Market - Opportunity Assessment |
9.1 Gambia Pneumococcal Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Gambia Pneumococcal Vaccine Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Gambia Pneumococcal Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Gambia Pneumococcal Vaccine Market Opportunity Assessment, By End Users, 2021 & 2031F |
9.5 Gambia Pneumococcal Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Gambia Pneumococcal Vaccine Market - Competitive Landscape |
10.1 Gambia Pneumococcal Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Gambia Pneumococcal Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |